$AEHR

Aehr Test Systems Q1FY27 Results: Revenue jumps 200% to $33.0 million

Aehr Test Systems reported Q1FY27 revenue of $33.0M, up 200% YoY, beating estimates. EPS was $0.28, exceeding expectations. Bookings reached $46.7M, with a book-to-bill ratio of 1.4. The company raised FY27 revenue guidance to $150M. Aehr's stock rose 14.67% post-results but later fell 5%.

Original reporting
Published Nov 2, 2026, 10:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aehr Test Systems Q1FY27 Results: Revenue jumps 200% to $33.0 million — source image
Decision brief

The 30-second read

$AEHRBullishMed
01

Why it matters

Earnings beat and guidance raise are primary news; likely to attract short‑term buying interest.

02

Market read

Micro‑cap earnings surprise with guidance lift; potential catalyst for sector peers.

03

What to watch

Backlog concentration in a single hyperscale customer could pose concentration risk.

Relevance 7/10Novelty 7/10Timing: today

Background

Aehr Test Systems reported record Q1 FY27 results, beating estimates and raising full‑year revenue guidance.

Company-level read

Ticker impact

$AEHRBullishHigh confidence
Context

Q1 FY27 earnings beat expectations and guidance raised to $150M, a fresh disclosure.

Expected impact

upward pressure as investors price in higher revenue outlook

Evidence & confidence

First report of earnings beat and raised guidance for a micro‑cap; market typically rewards such surprise.

Market effects

Strong AI test‑equipment demand may boost related semiconductor equipment peers.

Positive for US AI‑hardware supply chain.

Limited to niche AI test‑equipment market.

Counterpoint

Recent price drop suggests short‑term profit taking; risk if demand softens.

Key entities

  • Aehr Test Systems

    Semiconductor test equipment provider.

  • Gayn Erickson

    CEO of Aehr Test Systems.

Related articles

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.

$AAPLMed

US Stock Futures Trade Mixed Premarket As AAPL Margin Concerns Weigh On Tech — PLTR, AMD, AEHR In Focus

US stock futures were mixed on Tuesday, with AAPL down 4.5% premarket due to margin concerns despite strong Q4 revenue. ORCL rose 0.4% after a $20B share sale plan. PLTR fell 5% despite beating earnings. NVDA gained 1.3%, MRVL up 2% on acquisition news, AMD up 2.4% ahead of earnings. AEHR surged 15.5% on record revenue and strong outlook. Midterm elections and earnings calendar also in focus.

$AEHRMed

Aehr Test Systems (AEHR) Q1 2027 Earnings Call Transcript

Aehr Test Systems (AEHR) reported Q1 2027 non-GAAP net income of $9.4M, up 163% sequentially. Revenue outlook raised to $150M, up 200% YoY. Bookings totaled $46.7M, with a backlog of $109.3M. Demand for AI, silicon photonics, and power semiconductor solutions is driving growth. Key customers include AI processor and accelerator suppliers.

$AEHRHighAI 8/10

Why Is AEHR Stock Surging 10% Overnight?

Aehr Test Systems (AEHR) reported Q1 revenue of $33 million, up 200% year-on-year, and raised its fiscal 2027 revenue outlook to $150 million. The company's strong bookings and backlog of $109.3 million boosted investor confidence, driving a 10% overnight stock surge.

$AAPLHighAI 8/10

Apple, Palantir, Marvell Technology, Oracle and Aehr Test Systems: Why These 5 Stocks Are on Investors' Radars Today

Apple (AAPL) closed down 1.83% at $338.32, reporting Q4 revenue of $114.48B, up 12% YoY, and EPS of $2.10. Palantir (PLTR) fell 3.13% to $178.34, with Q3 revenue up 96% YoY. Marvell (MRVL) plunged 12.72% to $171.41 after announcing a $115B acquisition. Oracle (ORCL) dropped 8.76% to $119.22. Aehr (AEHR) fell 6.23% to $51.47, reporting Q1 revenue up 200% YoY.